Company
ImmunoPrecise Antibodies Ltd (NASDAQ: IPA) In 2025: Is This Company Worth Thinking About Investing In?
In the last trading session, 1.42 million shares of the ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) were traded, and its beta was 0.46. Most recently the company’s
